🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

10+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 10 of 10 recruiting trials for “immunoglobulin-a-vasculitis”

Phase 1RecruitingNCT07054684 ↗

Study of BHV-1400 in IgA Nephropathy

🏥 Biohaven Therapeutics Ltd.📍 12 sites📅 Started Jul 2025View details ↗
Phase 3RecruitingNCT07024563 ↗

Study of Ravulizumab in Pediatric Participants With Primary IgAN

🏥 Alexion Pharmaceuticals, Inc.📍 14 sites📅 Started Jun 2025View details ↗
Phase 4RecruitingNCT07315191 ↗

Finerenone Therapy for Pediatric HSPN With Mild Proteinuria

🏥 Capital Institute of Pediatrics, China📍 1 site📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT06797518 ↗

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📍 16 sites📅 Started Feb 2025View details ↗
Phase 4RecruitingNCT06676384 ↗

Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

👨‍⚕️ Jonathan Barratt, PhD, FRCP, University of Leicester📍 12 sites📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT06291376 ↗

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

🏥 Alexion Pharmaceuticals, Inc.📍 267 sites📅 Started Mar 2024View details ↗
Phase 3RecruitingNCT05797610 ↗

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

👨‍⚕️ Clinical Trials, Hoffmann-La Roche📍 20 sites📅 Started Aug 2023View details ↗
NARecruitingNCT05951517 ↗

Mycophenolate Mofetil in Gastrointestinal Henoch-Schonlein Purpura

👨‍⚕️ Weiping Tan, PhD, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University📍 1 site📅 Started Jan 2023View details ↗
Phase 2, PHASE3Enrolling by InvitationNCT05248659 ↗

Phase 2/3 Open-Label Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy

🏥 Otsuka Pharmaceutical Development & Commercialization, Inc.📍 1 site📅 Started Apr 2022View details ↗
NARecruitingNCT03647852 ↗

Clinical Study on Strategy for Refractory Henoch-Schönlein Purpura

👨‍⚕️ Li Sun, MD, Children's Hospital of Fudan University📍 3 sites📅 Started Sep 2019View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →